TNF and inflammatory bowel disease: Forty-three (65%) children with VEO-IBD were on stable maintenance therapy during the study, including aminosalicylates, immunomodulators, anti-TNF-α antibody therapy, steroids, and exclusive enteral nutrition therapy.